论文部分内容阅读
央视一则“1300%的利润,是谁在推高药价”的新闻在5月17日被各大网站推上了首页的显要位置,而后便是发改委采取四大措施加强药品管理,降低虚高药价……其实,类似于“一种出厂价15.5元的药品,经过医药公司、医药代表、医生等环节,最后价格涨到了213元售卖到患者手中”的现象,人们早已见怪不怪,但在新医改政策出台之后,为何这样的现象依然屡禁不止?诚然,药品层层加价的过程来源于各个环节管理上的疏漏,但导致最终发放到患者手中的高价药的结果,医院的管理者们也有着不可推卸的责任。也许,下面介绍的陕西省妇幼保健院在物价管理方面所做出的种种举措值得医院管理者们借鉴一二。
CCTV a “1300% of the profits, who is pushing drug prices ” news on May 17 was the major sites on the home page prominent position, and then is the NDRC to take four measures to strengthen drug management, In fact, similar to “a 15.5 yuan ex-factory price of medicines, after the pharmaceutical companies, pharmaceutical representatives, doctors and other sectors, the final price rose to 213 yuan sold to the hands of patients” phenomenon, people have long been However, after the introduction of the new health care reform policy, why is such a phenomenon still repeated? Admittedly, the process of drug price increases comes from omissions in all aspects of management. However, the result of the high-priced drugs eventually being distributed to the patients, the hospital The managers also have an unshirkable responsibility. Perhaps, the following describes the price of maternal and child health care centers in Shaanxi Province made a variety of measures worthy of hospital managers learn from one or two.